BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9663897)

  • 1. Clinical validation of PD Adequest software: modeling error assessment.
    Amici G; Mastrosimone S; Da Rin G; Bocci C; Bonadonna A
    Perit Dial Int; 1998; 18(3):317-21. PubMed ID: 9663897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of the PD Adequest mathematical model in pediatric patients on chronic peritoneal dialysis.
    Verrina E; Amici G; Perfumo F; Trivelli A; Canepa A; Gusmano R
    Perit Dial Int; 1998; 18(3):322-8. PubMed ID: 9663898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST International Study Group.
    Vonesh EF; Story KO; O'Neill WT
    Perit Dial Int; 1999; 19(6):556-71. PubMed ID: 10641777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal dialysis kinetic modeling: validation in a multicenter clinical study.
    Vonesh EF; Burkart J; McMurray SD; Williams PF
    Perit Dial Int; 1996; 16(5):471-81. PubMed ID: 8914177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of PD Adequest 2.0 for pediatric dialysis patients.
    Warady BA; Watkins SL; Fivush BA; Andreoli SP; Salusky I; Kohaut EC; Vonesh EF
    Pediatr Nephrol; 2001 Mar; 16(3):205-11. PubMed ID: 11322365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal function and adequacy calculations: current programs versus PD Adequest 2.0.
    Teixidó-Planas J
    Perit Dial Int; 2002; 22(3):386-93. PubMed ID: 12227398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Validation of a Peritoneal Dialysis Prescription Model in the PatientOnLine Software.
    Hodzic E; Rasic S; Klein C; Covic A; Unsal A; Cunquero JM; Prischl FC; Gauly A; Kalicki RM; Uehlinger DE
    Artif Organs; 2016 Feb; 40(2):144-52. PubMed ID: 26147618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume-Based Peritoneal Dialysis Prescription Guide to Achieve Adequacy Targets.
    Akonur A; Firanek CA; Gellens ME; Hutchcraft AM; Kathuria P; Sloand JA
    Perit Dial Int; 2016; 36(2):188-95. PubMed ID: 26293841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are we underestimating the problem of ultrafiltration in peritoneal dialysis patients?
    McCafferty K; Fan SL
    Perit Dial Int; 2006; 26(3):349-52. PubMed ID: 16722028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icodextrin modeling error with PD ADEQUEST, version 2.0.
    Amici G; Da Rin G; Bocci C
    Perit Dial Int; 2001; 21(5):516-8. PubMed ID: 11757837
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of oral administration of losartan, prazosin, and verapamil on peritoneal solute transport in continuous ambulatory peritoneal dialysis patients.
    Rojas-Campos E; Cortés-Sanabria L; Martínez-Ramírez HR; González L; Martín-del-Campo F; González-Ortiz M; Cueto-Manzano AM
    Perit Dial Int; 2005; 25(6):576-82. PubMed ID: 16411525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of icodextrin in PD Adequest 2.0.
    Vonesh EF; Story KO; Douma CE; Krediet RT
    Perit Dial Int; 2006; 26(4):475-81. PubMed ID: 16881343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulating inadequate dialysis and its correction using an individualized patient-derived nomogram.
    Lee AJ; Kho K; Chia KS; Oi TL; Yap C; Foong PP; Lau YW; Lim LK; Aragon E; Liew CW; Yap HK
    Pediatr Nephrol; 2009 Dec; 24(12):2429-38. PubMed ID: 19609568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the PD adequest program in Japanese patients on peritoneal dialysis.
    Katsutani M; Yorioka N; Ito T; Naito T; Kanahara K; Oda H; Yamakido M
    Int J Artif Organs; 1999 Sep; 22(9):600-3. PubMed ID: 10532428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance study in peritoneal dialysis using PD Adequest software.
    Amici G; Viglino G; Virga G; Gandolfo C; Da Rin G; Bocci C; Cavalli PL
    Perit Dial Int; 1996; 16 Suppl 1():S176-8. PubMed ID: 8728188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic Modeling of Incremental Ambulatory Peritoneal Dialysis Exchanges.
    Guest S; Leypoldt JK; Cassin M; Schreiber M
    Perit Dial Int; 2017; 37(2):205-211. PubMed ID: 28096442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of peritoneal dialysis prescription using computer models of peritoneal transport.
    Haraldsson B
    Perit Dial Int; 2001; 21 Suppl 3():S148-51. PubMed ID: 11887810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
    Fang W; Mullan R; Shah H; Mujais S; Bargman JM; Oreopoulos DG
    Perit Dial Int; 2008; 28(1):35-43. PubMed ID: 18178946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ionized sodium concentrations on ultrafiltration rate in peritoneal dialysis using lactate and lactate/bicarbonate solutions.
    La Milia V; Limardo M; Crepaldi M; Locatelli F
    Perit Dial Int; 2009; 29(2):158-62. PubMed ID: 19293352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extended assessment of peritoneal transport kinetics of substances and water as an important element of integrated dialysis care].
    Baczyński D; Antosiewicz S; Waniewski J; Marciniak M; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):110-3. PubMed ID: 15603317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.